Korro Bio KRRO
NASDAQ KRRO
$13.25 +0.29 (+2.24%)
As of: Aug 21, 2026 · 1:44 PM EDT

Korro Bio (KRRO) Other financing activities (2018 - 2026)

Korro Bio's (KRRO) quarterly Other financing activities came in at $17000.0 in Q1 2026, down 97.52% on a QoQ basis from $685000.0 in Q4 2025.

Korro Bio (KRRO) Other financing activities (2018 - 2026) Analysis & Trends

Korro Bio (KRRO) has 8 years of Other financing activities data on file, last reported at $17000.0 in Q1 2026.

  • Quarterly Other financing activities changed N/A year-over-year to $17000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $702000.0 (down 99.58% YoY) and the FY2025 annual result came in at $685000.0, down 98.98% from the prior year.
  • Other financing activities slipped to $17000.0 in Q1 2026, from $685000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $100.0 million in Q4 2024 to a low of -$351000.0 in Q4 2023.
  • A 5-year average of $12.0 million and a median of $139000.0 in 2022 frame the typical range for Other financing activities.
  • Annual changes were most pronounced in 2022 — Other financing activities tumbled 13300.0% — and 2024, when it jumped 28590.03%.
  • Tracing KRRO's Other financing activities over 5 years: stood at -$134000.0 in 2022, then slumped by 161.94% to -$351000.0 in 2023, then jumped by 28590.03% to $100.0 million in 2024, then tumbled by 99.32% to $685000.0 in 2025, then tumbled by 97.52% to $17000.0 in 2026.
  • The last three Other financing activities figures came in at $17000.0 (Q1 2026), $685000.0 (Q4 2025), and -$177000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.50 Bn 131.65 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.10 Bn 78.10 Bn 3.93 Bn
3 Argenx Se 65.59 Bn 60.41 Bn 1.37 Bn
4 Moderna 56.75 Bn 51.62 Bn 52.00 Mn
5 BeOne Medicines 42.11 Bn 37.01 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.64 Bn 28.33 Bn 992.69 Mn
7 BioNTech SE 27.80 Bn 9.41 Bn 668.28 Mn
8 Insmed 27.51 Bn 26.35 Bn 358.27 Mn
9 Royalty Pharma 27.29 Bn 26.45 Bn -
10 Korro Bio 233.44 Mn 118.41 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 -21,000.00
Jun 30, 2026 -21,000.00
Mar 31, 2026 17,000.00
Mar 31, 2026 17,000.00
Dec 31, 2025 685,000.00
Dec 31, 2025 685,000.00
Sep 30, 2025 -177,000.00
Sep 30, 2025 -177,000.00
Jun 30, 2025 177,000.00
Jun 30, 2025 177,000.00
Dec 31, 2024 100.00 Mn
Dec 31, 2024 100.00 Mn
Jun 30, 2024 67.25 Mn
Jun 30, 2024 67.25 Mn
Mar 31, 2024 139,000.00
Mar 31, 2024 139,000.00
Dec 31, 2023 -351,000.00
Dec 31, 2023 -351,000.00
Sep 30, 2023 216,000.00
Sep 30, 2023 216,000.00